This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)
C3_UTERUS_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
167 |
4. Check minimum number of eventsNone |
167 |
5. Include endpointsNone |
167 |
6. Filter based on genotype QC (FinnGen only) |
167 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 167 | 167 | - |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | - |
| Median age at first event (years) | 54.73 | 54.73 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
48
8.64
23.86
4.8
1.5
92.6
37.6
u/ml
0.60
34
48
13
22
6.32
7.50
1.4
1.4
183.4
87.3
pmol/l
0.46
13
22
93
597
2.26
6.22
9.6
4.9
4.6
4.4
e9/l
0.14
78
500
23
85
2.98
4.92
1.5
1.6
0.2
0.2
g/l
0.60
23
77
83
559
1.96
4.40
5.8
3.1
33.4
34.7
g/l
1.34
74
506
68
441
1.91
3.93
3.4
3.3
—
—
—
0
0
70
468
1.85
3.62
5.0
3.8
—
—
—
0
0
40
223
2.04
3.52
2.5
2.0
—
—
—
0
0
37
206
2.02
3.25
2.8
3.1
4.8
5.0
e6/l
0.05
22
104
29
150
2.13
3.09
3.6
2.2
21.2
20.9
%
0.03
23
129
64
450
1.68
2.62
4.0
2.0
2.4
2.4
mmol/l
0.01
53
371
78
582
1.64
2.51
6.2
4.0
1.2
1.2
mmol/l
0.09
71
516
85
650
1.63
2.47
6.9
4.5
1.2
1.2
mmol/l
0.00
73
557
31
180
1.89
2.40
3.0
2.1
12.4
12.1
umol/l
0.06
26
161
19
95
2.13
2.21
1.7
1.7
—
—
—
0
0
29
170
1.85
2.18
1.6
1.3
—
—
—
0
0
35
218
1.77
2.17
2.4
2.8
0.8
1.6
e6/l
1.83
21
114
105
883
1.51
1.77
8.1
4.7
81.6
78.2
u/l
0.54
99
793
49
355
1.54
1.68
3.4
3.2
0.1
0.6
e6/l
3.14
36
265
24
147
1.74
1.58
3.8
3.8
2.0
1.7
mmol/l
0.14
19
109
42
301
1.53
1.50
4.2
2.4
2.5
2.5
mmol/l
1.95
35
256
6
23
2.67
1.38
1.3
2.3
—
—
—
0
0
85
715
1.38
1.27
4.2
3.6
6.8
6.9
mmol/l
0.04
80
654
10
50
2.06
1.19
1.0
1.2
—
—
—
0
0
45
343
1.43
1.18
2.2
2.4
2.4
3.4
mg/l
3.74
36
285
21
137
1.61
1.12
4.6
3.0
0.7
2.8
mmol/l
1.01
16
113
7
36
1.98
0.98
2.3
1.5
—
—
—
0
0
30
224
1.41
0.88
1.7
1.7
—
—
—
0
0
71
606
1.30
0.88
2.2
2.1
89.7
95.0
pmol/l
0.42
39
261
13
80
1.68
0.87
1.4
1.4
—
—
—
0
0
8
46
1.78
0.84
1.1
1.2
—
—
—
0
0
0
27
0.00
0.78
0.0
2.1
—
1.7
—
0
19
19
134
1.47
0.75
2.9
3.3
—
—
—
0
0
21
153
1.43
0.71
13.7
8.8
—
—
—
0
0
5
27
1.88
0.69
1.8
1.1
—
—
—
0
0
5
28
1.81
0.66
1.0
1.4
—
—
—
0
0
40
330
1.28
0.63
2.0
1.7
1066.5
1225.4
nmol/l
0.64
28
249
88
963
0.82
0.61
4.5
4.1
15.3
15.1
pmol/l
0.31
77
859
16
115
1.43
0.59
4.6
2.7
138.5
87.0
ng/l
—
10
97
56
485
1.23
0.58
3.5
2.7
254.5
91.6
ug/l
1.56
50
431
18
133
1.40
0.58
1.8
2.5
2.8
3.7
ug/l
0.67
13
115
6
36
1.69
0.57
1.0
1.4
—
—
—
0
0
6
36
1.69
0.57
1.0
1.4
—
—
—
0
0
9
59
1.55
0.56
1.0
1.1
—
—
—
0
0
28
225
1.29
0.54
1.2
1.3
0.7
1.0
u/ml
—
6
53
62
547
1.21
0.54
2.1
2.3
79.3
80.6
nmol/l
0.14
54
472
22
171
1.33
0.53
1.5
1.7
—
—
—
0
0
22
172
1.32
0.51
1.4
1.7
—
—
—
0
0
7
48
1.48
0.47
1.1
1.2
—
—
—
0
0
7
48
1.48
0.47
1.1
1.2
—
—
—
0
0
15
195
0.75
0.44
1.5
1.3
33.0
40.7
iu/ml
—
6
72
5
32
1.58
0.42
1.0
1.2
—
—
—
0
0
5
32
1.58
0.42
1.6
1.7
—
—
—
0
0
123
1171
1.19
0.41
21.1
14.9
36.5
22.0
mg/l
3.73
107
922
53
473
1.18
0.40
3.9
3.1
4820.2
1832.0
ng/l
0.43
43
404
5
35
1.44
0.39
1.4
1.8
27.8
37.8
u/l
—
5
29
41
358
1.19
0.39
1.3
1.6
21.4
22.7
nmol/l
0.17
34
302
9
67
1.36
0.39
3.4
3.5
25.4
25.8
mmol/l
—
9
67
6
41
1.48
0.36
2.3
1.6
—
—
—
0
0
51
565
0.86
0.36
2.3
2.4
—
—
—
0
0
13
100
1.33
0.35
2.9
2.7
1.2
1.2
mmol/l
0.00
13
84
110
1151
0.87
0.33
4.7
5.3
2.7
2.6
mmol/l
0.18
96
1033
68
627
1.14
0.33
2.6
2.7
76.4
42.1
u/l
0.75
60
573
15
183
0.80
0.29
1.3
1.3
8.8
11.1
u/ml
—
8
66
30
263
1.17
0.28
2.4
2.2
28602.3
13121.1
umol/l
0.23
22
218
30
264
1.17
0.27
1.7
1.7
3.3
1.5
mg/l
0.54
24
203
11
137
0.79
0.25
1.2
1.4
—
—
—
0
0
93
887
1.11
0.24
4.3
4.3
21.2
15.2
mm/h
2.36
82
798
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
26
290
0.88
0.20
5.3
4.6
53.0
82.3
ng/l
0.49
21
256
68
645
1.09
0.18
7.6
6.3
0.0
0.0
estimate
0.00
11
95
67
636
1.09
0.18
5.4
4.6
0.0
0.0
estimate
0.00
11
102
11
131
0.83
0.17
3.5
4.5
37.2
33.3
%
—
5
83
7
62
1.13
0.17
1.3
1.3
—
—
—
0
0
107
1037
1.09
0.17
22.1
14.3
69.7
68.9
ml/min/173m2
0.13
91
823
108
1112
0.92
0.17
4.1
4.7
4.7
4.6
mmol/l
0.34
93
1003
68
648
1.08
0.16
5.5
4.5
0.0
0.0
estimate
0.50
11
100
59
559
1.09
0.16
3.8
4.2
28.9
97.0
ng/l
0.60
46
407
105
1024
1.07
0.12
25.4
17.1
37.3
38.0
%
0.28
66
632
107
1094
0.94
0.11
4.0
4.6
1.6
1.6
mmol/l
0.03
90
984
47
493
0.94
0.11
7.0
5.0
—
—
—
0
0
5
60
0.83
0.08
1.0
1.1
—
119.7
—
0
17
125
1233
1.05
0.07
26.6
18.6
4.0
4.0
mmol/l
0.30
120
1190
114
1157
0.95
0.07
4.7
4.9
6.1
6.1
mmol/l
0.05
97
1032
9
88
1.02
0.07
1.9
1.5
—
—
—
0
0
110
1110
0.97
0.03
6.4
6.3
41.0
41.1
mmol/mol
0.02
91
1016
14
148
0.94
0.02
4.6
3.7
787.9
314.7
ng/l
0.96
14
138
33
331
1.00
0.00
6.9
5.0
0.0
0.0
estimate
—
10
96
122
1219
1.00
0.00
12.5
8.9
22.5
21.2
u/l
0.30
117
1162
105
1049
1.00
0.00
3.6
4.1
1.3
1.2
mmol/l
0.77
88
929
122
1223
0.99
0.00
25.8
17.3
81.3
75.3
umol/l
0.86
122
1223
112
1117
1.01
0.00
5.1
5.2
1.9
2.0
mu/l
0.16
99
1011
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
917.4
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
0.00
2.5
2.1
0.9
1.0
%
—
8
79
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
31
310
1.00
0.00
1.4
1.7
397.1
480.9
pmol/l
1.16
22
252
0
6
0.00
0.00
0.0
2.3
—
1.2
—
0
6
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_UTERUS_NAS_EXALLC – Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).